Bunnage Mark E. sold VRTX

February 17, 2026 · Form 4 insider transaction

Bunnage Mark E. sold 1,110 shares of Vertex Pharmaceuticals Incorporated at $483.75 per share, a transaction worth $537.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.